| Opportunity ID: |
323520 |
| Opportunity Number: |
NOT-NS-20-020 |
| Opportunity Title: |
Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative: Pain Management Effectiveness Research Network: Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) |
| Opportunity Category: |
Discretionary |
| Opportunity Category Explanation: |
|
| Funding Instrument Type: |
Cooperative Agreement |
| Category of Funding Activity: |
Health |
| Category Explanation: |
|
| CFDA Number(s): |
93.853 |
| Eligible Applicants: |
State governments
County governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: |
|
| Agency Code: |
HHS-NIH11 |
| Agency Name: |
Department of Health and Human Services
National Institutes of Health |
| Posted Date: |
Jan 06, 2020 |
| Last Updated Date: |
Jan 06, 2020 |
| Estimated Synopsis Post Date: |
Jan 20, 2020 |
| Fiscal Year: |
2020 |
| Award Ceiling: |
$500,000 |
| Award Floor: |
|
| Estimated Total Program Funding: |
$800,000 |
| Expected Number of Awards: |
2 |
| Description: |
The purpose of this Notice is to inform potential applicants that the National Institute of Neurological Disorders and Stroke (NINDS) intends to publish a re-issuance of funding opportunity announcement RFA-NS-19-021 to solicit applications for clinical trial planning and implementation to generate evidence-based pain management best practices for the use of existing medications or devices for specific pain conditions. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The funding opportunity announcement is expected to be published in December 2019 with an expected application due date in March 2020. Applicant organizations may submit more than one application, provided each application proposes a distinct clinical trial. This funding opportunity announcement will utilize the UG3/UH3 bi-phasic activity code. |
| Version: |
1 |
